Condition: Acute Kidney Injury · Cardiac Surgery Associated - Acute Kidney Injury · Sponsor: Onassis Cardiac Surgery Centre
The main goal of this clinical trial is to learn if evaluation by ultrasound of venous congestion of liver and kidneys can guide treatment and prevent and treat acute kidney injury post cardiac surgery (CSA-AKI). Participants will: Be evaluated by liver and kidney veins ultrasound (treatment group) or a placebo post CSA-AKI. Fluid management for the treatment group will be based on a score that emerges from this evaluation (Venous Excess Ultrasound Score, VEXUS). Kidney function will be daily monitored and followed-up for 7 days and until discharge. Daily fluid balance and laboratory examination will be performed. Data will be recorded and collected and a statistical analysis will provide the results that will show or not a probable superiority of this evaluation comparing to the usual care.
This description comes directly from the study's public registry record.
Stavros Dimopoulos, PhD, EDIC · 00306973956974 · stdimop@gmail.com
Konstantina Kolonia, MD, MSc · 00306958261393 · kon.kolonia@gmail.com
Always discuss trial participation with your own doctor first.
| Onassis Cardiac Surgery Center | Athens, Kallithea, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06972082